Navigation Links
Welders may be at increased risk for brain damage
Date:4/7/2011

Workers exposed to welding fumes may be at increased risk of damage to the same brain area harmed by Parkinson's disease, according to a new study by researchers at Washington University School of Medicine in St. Louis.

Fumes produced by welding contain manganese, an element that scientists have linked to neurological problems including Parkinson's disease-like symptoms.

"In the United States alone, there are more than 1 million workers who perform welding as a part of their jobs," says Brad Racette, MD, professor of neurology at Washington University School of Medicine. "If further investigation of this potential link between neurotoxic effects and these fumes proves it is valid, it would have a substantial public-health impact for the U.S. workforce and the economy."

The study appears online April 6, 2011, in Neurology, the medical journal of the American Academy of Neurology.

The study involved 20 welders with no symptoms of Parkinson's disease, 20 people with Parkinson's disease who were not welders and 20 people who were not welders and did not have Parkinson's. The welders were recruited from two shipyards and one metal fabrication company, and each had an average of 30,000 hours of lifetime welding exposure.

All participants were given brain PET and MRI scans and motor skills tests. A neurologist who specializes in movement disorders also examined all participants. The welders' average blood manganese levels were found to be two times the upper limits of normal blood manganese levels established in prior studies of general populations.

In one area of the brain, PET scans indicated that welders had an average 11.7 percent reduction in a marker of the chemical dopamine compared to people who did not weld. Dopamine helps nerve cells communicate and is decreased in specific brain regions in people with Parkinson's disease. The welders' motor skills test scores also showed mild movement difficulties that were not as extensive as those found in the early Parkinson's disease patients.

Although the same area of the brain was affected as in Parkinson's disease, the pattern of effects within this area was reversed. Parkinson's disease normally has the greatest impact on the rear of a structure known as the putamen. In the welders, the largest drop in the marker for dopamine occurred in a structure behind the putamen known as the caudate.

"While these changes in the brain may be an early marker of neuron death related to welding exposure, the damage appeared to be different from those of people with full-fledged Parkinson's disease," Racette says. "MRI scans also revealed brain changes in welders that were consistent with manganese deposits in the brain."

Racette and his colleagues plan a larger follow-up study to clarify the potential links between welding and brain damage.


'/>"/>

Contact: Michael C. Purdy
purdym@wustl.edu
314-286-0122
Washington University School of Medicine
Source:Eurekalert  

Related medicine news :

1. Migraine Linked to Increased Heart Attack Risk
2. Attorney Joe Belluck Hails Department Of Defense For Increased Funding Of Mesothelioma Research
3. Increased HAART coverage associated with 50 percent drop
4. RetireSafe Survey Says Seniors Are Struggling With Increased Costs Without an Increased Social Security Cost of Living Adjustment
5. Arsenic exposure activates an oncogenic signaling pathway; leads to increased cancer risk
6. Increased Government Scrutiny of Companies That Use Independent Contractors, Consultants, or Freelancers: Are You Ready? Learn More at Complimentary Breakfast Briefing
7. Hormone thought to slow aging associated with increased risk of cancer death
8. Hormone replacement therapy linked to increased lung cancer risk
9. NACDS RxIMPACT "Hill Day" Features More Advocates Increased Focus on Medication Adherence
10. Weight-bearing exercise does not prevent increased bone turnover during weight loss
11. Increased radiation dose does not increase long-term side effects for prostate cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Welders may be at increased risk for brain damage
(Date:3/23/2017)... Yardley, PA (PRWEB) , ... March 23, 2017 ... ... received Patient Oriented Disease Management Accreditation from the NCQA. The accreditation covers StayWell’s ... programs. , Accredited status is granted to organizations that have excellent programs ...
(Date:3/23/2017)... ... , ... The TouchPoint Solution, home of Buzzies *, is boosting the ... , “Buzzies change the way we interact with stress and live our day-to-day lives,” ... date in December 2016, The TouchPoint Solution has sold more than $750,000 in product ...
(Date:3/23/2017)... , ... March 23, 2017 , ... After raising more ... FaceCradle , the most-funded travel pillow in crowdfunding history, has established a ... its wildly popular travel innovation to Americans. , “We’re excited to be operating on ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... today announced rapid completion of the strategic executive team expansion needed to further ... to the ChenMed executive team,” says Christopher Chen, MD, ChenMed Chief Executive Officer. ...
(Date:3/23/2017)... ... March 23, 2017 , ... Natural Subsistence, ... aspects of people’s health and nutrition, announced its product Leyzene is now available ... Subsistence develops nutritional supplements that help people improve all aspects of their health ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... MUMBAI , March 23, 2017 ... de Piramal Enterprises Limited, anuncia el nombramiento de ... PPS ofrece una plataforma de servicios integrados completa ... Needleman desempeñará un cargo clave en el crecimiento ... comercial, Needleman será responsable de impulsar todas las ...
(Date:3/23/2017)... 23, 2017  Galmed Pharmaceuticals Ltd. (Nasdaq: ... clinical-stage biopharmaceutical company focused on the development of ... nonalcoholic steatohepatitis, or NASH, and other liver diseases, ... twelve months ended December 31, 2016, and announced new ... demonstrating Aramchol™,s potential direct effect on liver fibrosis. ...
(Date:3/23/2017)... 23, 2017 ReNeuron reported in December ... in chronic stroke patients, despite not meeting the three-month time ... the Action Research Arm Test (ARAT). As a result, the ... controlled clinical study in 2017. Beyond CTX, we expect safety ... 2017 and Phase I data from its critical limb ischaemia ...
Breaking Medicine Technology: